ANDA 74478, held by Chartwell RX. Metoclopramide Hydrochloride.
As of Nov 21, 2026, ANDA 74478 (Metoclopramide Hydrochloride), held by Chartwell RX, was first approved by FDA on Oct 5, 1995, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 5, 1995 | Original application | Approved | None posted |
| Metoclopramide HydrochlorideEQ 5MG BASE · tablet;oral | Metoclopramide Hydrochloride | Discontinued |
| Metoclopramide HydrochlorideEQ 10MG BASE · tablet;oral | Metoclopramide Hydrochloride | Discontinued |
| Feb 25, 2003 | Supplement 6Labeling | Approved | None posted |
| Nov 25, 2002 | Supplement 5Labeling | Approved | None posted |
| May 20, 2002 | Supplement 4Manufacturing | Approved | None posted |
| May 20, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Nov 21, 2001 | Supplement 2Manufacturing | Approved | None posted |
| Nov 21, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Oct 5, 1995 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters